Physician profile
Jay R Joshi
NPI 1447203153
$26,030.91
in general payments reported to CMS, 2019-2025
26 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,203 · 2020: $1,933 · 2021: $3,207 · 2022: $59.63 · 2023: $705 · 2024: $1,567 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,668 · Honoraria: $1,828 · Consulting Fee: $1,367 · Food and Beverage: $426 · Travel and Lodging: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,667.50 |
| Honoraria | $1,828.00 |
| Consulting Fee | $1,366.67 |
| Food and Beverage | $425.97 |
| Travel and Lodging | $339.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $10,722.85 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $4,382.69 | 2019 | |
| Baxter Healthcare | $3,616.00 | 2019-2025 | |
| Redhill Biopharma INC. | $3,120.00 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $1,732.49 | 2019-2023 | Exparel |
| Instrumentation Laboratory Company | $1,200.00 | 2024 | |
| Alnylam Pharmaceuticals INC. | $450.00 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.16 | 2019-2021 | |
| Sentynl Therapeutics, INC. | $111.52 | 2019-2020 | |
| Pfizer INC. | $77.19 | 2019 | |
| Vertical Pharmaceuticals, LLC | $70.52 | 2019-2020 | |
| Pernix Therapeutics Holdings, INC. | $56.51 | 2019 | |
| Djo, LLC | $53.57 | 2023 | Cmf |
| Biohaven Pharmaceutical Holding Company LTD. | $43.14 | 2022 | |
| Si-Bone, INC. | $40.61 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $32.48 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $30.87 | 2021 | |
| Abbott Laboratories | $23.63 | 2023 | Eterna |
| Biodelivery Sciences International, INC. | $21.62 | 2020 | |
| Amniox Medical, INC. | $18.40 | 2019 | |
| Scilex Pharmaceuticals INC. | $17.76 | 2019 | |
| Abbvie INC. | $16.27 | 2021 | |
| Kaleo, INC. | $16.23 | 2019 | |
| Almatica Pharma LLC | $15.79 | 2021 | |
| Bioventus LLC | $14.36 | 2019 | |
| Lilly USA, LLC | $12.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.